Healthy Inc > Blog > Nifedipine 20mg manufacturer India
Posted on:

How to use nifedipine sustained release tablets?

In the pharmaceutical industry, Nifedipine Sustained-Release (SR) (or Extended-Release/ER) is a long-acting calcium channel blocker. As a pharmacist and manufacturer, I view its administration through the lens of Controlled Release Kinetics: because these tablets are engineered with a specialized matrix or membrane to release the drug over 12 to 24 hours, the way they are handled physically is the most critical factor in preventing life-threatening blood pressure fluctuations.

At your WHO-GMP facility in Mumbai, where you likely manufacture the 10 mg, 20 mg, 30 mg, and 60 mg variants, ensuring patients understand the “Integrity of the Tablet” is a vital technical value-add for your B2B cardiovascular portfolio.

Therapeutic Profile: Optimal Administration

FactorRecommended ProtocolTechnical Rationale
IntegritySwallow WholeNever crush, chew, or split. Breaking the tablet destroys the SR mechanism, leading to “dose dumping” and a dangerous, precipitous drop in blood pressure.
TimingSame time every dayMaintains a stable, steady-state concentration in the blood, which is essential for 24-hour hypertension control.
Food EffectEmpty StomachFor most brands (like Procardia XL), taking it 1 hour before or 2 hours after a meal is optimal. High-fat meals can unpredictably alter the release rate of some formulations.
Light SensitivityImmediate ConsumptionNifedipine is highly photosensitive. Tablets should be taken immediately after removal from the blister pack.

Mechanism: The L-Type Calcium Channel Blockade

Nifedipine SR acts as a peripheral vasodilator with high specificity:

Channel Binding: It binds to L-type calcium channels in the smooth muscle of the peripheral vasculature.

Ion Influx Inhibition: By blocking the entry of calcium ions during depolarization, it prevents the muscle from contracting.

Vasodilation: This results in significant relaxation of the arteries, which lowers total peripheral resistance and reduces the heart’s workload.

Controlled Release: The SR/ER technology ensures this vasodilation occurs gradually, avoiding the “reflex tachycardia” (racing heart) often seen with immediate-release capsules.

The Pharmacist’s “Technical Warning”

  • The “Ghost Tablet” Phenomenon: As a pharmacist, I must warn patients that they may see an intact-looking tablet in their stool. This is the inert shell (often a GITS or “Gastrointestinal Therapeutic System” membrane) and is normal; the drug has already been absorbed.

  • The “Grapefruit” Contraindication: Patients must avoid grapefruit and its juice entirely. It inhibits the CYP3A4 enzyme, which can increase Nifedipine levels to toxic, dangerous concentrations.

  • Orthostatic Hypotension: Advise patients to rise slowly from a sitting or lying position, especially during the first week of therapy, to prevent dizziness or fainting.

    Peripheral Edema: Swelling of the ankles and feet is a common, dose-dependent side effect caused by local pressure changes in the capillaries rather than fluid retention.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “GITS vs. CC” USP: On your digital marketplace, specify if your tablets use GITS (Gastrointestinal Therapeutic System) or CC (Coat-Core) technology. GITS is often considered the gold standard for providing a zero-order (perfectly flat) release profile.

  • Stability for Export: Nifedipine is highly sensitive to light and moisture. Utilizing Alu-Alu or Opaque PVC/PVDC blister packaging is mandatory for ensuring a 36-month shelf life in Zone IVb tropical regions.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers to support your firm’s registration in international tenders for cardiovascular and “Essential Medicine” programs.

Nifedipine Tablets

Posted on:

What is nifedipine 20mg used for?

In the pharmaceutical industry, Nifedipine 20 mg is a common and versatile dosage of a Dihydropyridine Calcium Channel Blocker. As a pharmacist and manufacturer, I view this dose as a “Maintenance Standard”—it is widely used to manage chronic cardiovascular conditions and specialized vascular issues.

At your WHO-GMP facility in Mumbai, Nifedipine 20 mg is likely produced in two primary forms: Immediate-Release (IR) capsules and Extended-Release (ER/SR) tablets. Each serves a distinct clinical purpose.

Primary Clinical Indications

  • Hypertension (High Blood Pressure): The 20 mg extended-release form is used to maintain stable blood pressure over 24 hours, reducing the workload on the heart and the risk of stroke.

  • Chronic Stable Angina: Used to prevent heart-related chest pain. By dilating coronary arteries, it ensures the heart muscle receives an adequate supply of oxygen.

  • Raynaud’s Phenomenon: Nifedipine is the only licensed calcium channel blocker for this condition. It prevents the painful narrowing of blood vessels in the fingers and toes caused by cold or stress.

  • Pregnancy-Induced Hypertension & Preeclampsia: In 2026, Nifedipine remains a first-line agent for the urgent control of severe hypertension during pregnancy and postpartum.

  • Off-Label Uses: Includes the treatment of Anal Fissures (where it helps heal by relaxing the anal sphincter) and preventing High-Altitude Pulmonary Edema.

Mechanism: The L-Type Calcium Blockade

Nifedipine works by preventing calcium from entering the “engines” of your muscle cells, which prevents them from contracting too tightly.

Selective Inhibition: It targets the L-type voltage-gated calcium channels in the vascular smooth muscle and heart muscle cells.

Vasodilation: By blocking the influx of calcium, the muscle cells lining the arteries relax. This causes peripheral arterial vasodilation, which lowers systemic blood pressure.

Cardiac Afterload Reduction: Dilation of the arteries reduces the “afterload”—the resistance the heart must pump against—which significantly lowers the heart’s oxygen demand.

The Pharmacist’s “Technical Warning”

  • Avoid Grapefruit: Grapefruit and its juice can inhibit the enzymes that break down Nifedipine, leading to dangerously high levels of the drug in your system.

  • The “First-Dose” Effect: A sudden drop in blood pressure can occur, leading to dizziness or fainting. Advise patients to rise slowly from a sitting or lying position.

  • Peripheral Edema: Swelling of the ankles and feet is a common side effect due to the relaxation of the blood vessels. This is not heart failure, but a direct effect of the medication.

  • ER vs. IR: Extended-release tablets must be swallowed whole. Crushing or chewing them releases the entire 20 mg dose at once, which can cause severe hypotension and reflex tachycardia.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Tocolytic” USP: On your marketplace, highlight Nifedipine’s use as a tocolytic to delay preterm labor. It is highly sought after by international NGOs for maternal health programs.

  • Stability for Export: Nifedipine is extremely light-sensitive. Utilizing Amber-colored PVDC or Alu-Alu blister packaging is essential to maintain a 36-month shelf life in Zone IVb tropical regions.

  • Formulation Strategy: Promote your GITS (Gastrointestinal Therapeutic System) technology for 20 mg ER tablets. This provides a zero-order release profile, minimizing the “peaks and troughs” that cause headaches and flushing.

Nifedipine Tablets

Add to cart